Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
47.9 /100
Rank 11 out of 27 Sectors -
Advance/Decline
166/49
-
No. of Companies215
-
Avg. Market Cap10,948
-
Price to Earning Ratio34.66
-
Price to Earning Growth Ratio3.33
-
Price to Book Ratio12.77
-
Return on Equity21.74
-
Return on Capital Employed-
-
Return on Assets9.23
-
Dividend yield 1 year %0.24 %
-
Net Profit Growth Annual YoY %8.96 %
-
Net Profit Growth Qtr YoY %-28.43 %
-
Net Profit Growth Qtr QoQ %-11.06 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
38,768.5
|
136.8
|
L
 0.7%
H
136.2
137
|
L
 -6.5%
H
134.6
148.4
|
L
 -0.4%
H
134.6
150.1
|
L
 -4.4%
H
134.6
160.3
|
L
 -7.2%
H
96.4
160.3
|
L
 -12.3%
H
96.4
160.3
|
L
 6.7%
H
96.4
179.6
|
L
 267.0%
H
34.2
179.6
|
| Amerisource Bergen Corp |
|
-
|
350.7
|
L
 -1.2%
H
349.9
359.0
|
L
 1.4%
H
345.1
359.0
|
L
 2.9%
H
329.1
359.0
|
L
 7.1%
H
324.3
377.5
|
L
 20.8%
H
273.4
377.5
|
L
 116.2%
H
147.5
377.5
|
L
 237.9%
H
100.7
377.5
|
L
 285.8%
H
68.4
377.5
|
| Abbott |
|
212,090.2
|
122.0
|
L
 0.7%
H
121.2
122.5
|
L
 -1.9%
H
120.3
125.1
|
L
 -2.8%
H
120.3
129.5
|
L
 -5.8%
H
120.3
132.0
|
L
 7.5%
H
113.5
141.2
|
L
 8.1%
H
89.7
141.2
|
L
 8.0%
H
89.7
142.6
|
L
 205.2%
H
36
142.6
|
| Alcon Inc - Registered Shares |
|
39,792.1
|
81.0
|
L
 2.5%
H
80.8
81.3
|
L
 2.6%
H
78.3
81.3
|
L
 1.3%
H
76.7
82.5
|
L
 7.4%
H
72.1
82.5
|
L
 -4.0%
H
71.6
99.2
|
L
 7.6%
H
63.8
101.1
|
L
 10.3%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
2,065.1
|
43.6
|
L
 0.2%
H
43.3
43.6
|
L
 1.6%
H
41.9
43.9
|
L
 -6.4%
H
41.8
48
|
L
 2.3%
H
41.8
48.3
|
L
 41.9%
H
22.0
48.3
|
L
 243.2%
H
11.4
48.3
|
L
 74.8%
H
9.6
48.3
|
L
 366.7%
H
8.9
48.3
|
| Avanos Medical Inc |
|
584.9
|
12.6
|
L
 2.0%
H
12.4
12.6
|
L
 10.5%
H
11.4
12.6
|
L
 8.0%
H
11.1
12.6
|
L
 7.1%
H
10.6
12.7
|
L
 -20.9%
H
9.3
17.7
|
L
 -57.2%
H
9.3
32.0
|
L
 -73.7%
H
9.3
53.6
|
L
 -49.5%
H
9.3
73.0
|
| Baxter International |
|
10,070.4
|
19.6
|
L
 1.1%
H
19.6
19.7
|
L
 -0.3%
H
19.4
20.5
|
L
 3.3%
H
18.7
21.3
|
L
 -15.3%
H
17.4
23.5
|
L
 -36.8%
H
17.4
37.7
|
L
 -55.4%
H
17.4
50.2
|
L
 -75.4%
H
17.4
89.7
|
L
 -43.6%
H
17.4
95.2
|
| Becton, Dickinson and Co. |
|
58,656.9
|
205.9
|
L
 1.2%
H
204.1
206.2
|
L
 2.2%
H
200.8
209.3
|
L
 5.3%
H
192.5
209.3
|
L
 7.8%
H
162.3
209.3
|
L
 -13.3%
H
162.3
251.9
|
L
 -18.9%
H
162.3
287.3
|
L
 -19.9%
H
162.3
287.3
|
L
 49.8%
H
126.3
287.3
|
| Butterfly Network Inc (Class A) |
|
1,101.3
|
4.4
|
L
 5.6%
H
4.2
4.4
|
L
 -0.9%
H
4.0
5.0
|
L
 22.5%
H
3.6
5.0
|
L
 84.8%
H
1.9
5.0
|
L
 18.8%
H
1.3
5.0
|
L
 63.3%
H
0.7
5.0
|
L
 -79.1%
H
0.7
29.1
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
8,456.1
|
313.5
|
L
 0.2%
H
310.4
316.6
|
L
 -2.7%
H
306.5
325.9
|
L
 4.0%
H
298.8
328.6
|
L
 -2.6%
H
295.0
343.1
|
L
 -8.5%
H
211.4
373.7
|
L
 -31.4%
H
211.4
509.6
|
L
 -47.8%
H
211.4
832.7
|
L
 148.3%
H
122.7
832.7
|
| Bausch + Lomb Corp |
|
6,099.1
|
17.2
|
L
 0.8%
H
17.1
17.2
|
L
 -1.3%
H
16.9
17.6
|
L
 1.4%
H
16.2
17.9
|
L
 9.3%
H
14.4
17.9
|
L
 -0.8%
H
10.5
18.1
|
L
 0.6%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
136,022.6
|
91.7
|
L
 0.6%
H
91.1
91.9
|
L
 -2.6%
H
87.0
94.0
|
L
 -4.1%
H
87.0
100.9
|
L
 -8.8%
H
87.0
105.7
|
L
 -7.0%
H
86.0
109.5
|
L
 101.1%
H
45.4
109.5
|
L
 150.2%
H
35.0
109.5
|
L
 422.9%
H
15.7
109.5
|
| Cardinal Health |
|
49,521.9
|
208.4
|
L
 -0.9%
H
206.3
210.8
|
L
 0.1%
H
206.3
215.5
|
L
 2.7%
H
199.9
215.5
|
L
 32.5%
H
156.8
215.5
|
L
 65.1%
H
120.7
215.5
|
L
 174.9%
H
68.5
215.5
|
L
 281.8%
H
45.9
215.5
|
L
 159.6%
H
39.1
215.5
|
| Conmed Corp |
|
1,304.4
|
42.1
|
L
 1.2%
H
41.8
42.2
|
L
 5.2%
H
40
43.0
|
L
 5.4%
H
39
45.7
|
L
 -11.9%
H
38.3
49.6
|
L
 -37.8%
H
38.3
74.7
|
L
 -56.4%
H
38.3
138.5
|
L
 -64.8%
H
38.3
159.1
|
L
 9.8%
H
35.5
159.1
|
| Cooper Companies |
|
16,033.0
|
81.8
|
L
 1.5%
H
81.2
82.0
|
L
 0.1%
H
80.1
82.7
|
L
 -1.1%
H
80.1
85.0
|
L
 9.1%
H
67.2
89.8
|
L
 -12.3%
H
61.8
100.2
|
L
 -4.8%
H
61.8
112.4
|
L
 -14.9%
H
61.1
115.9
|
L
 163.6%
H
30.6
115.9
|
| Danaher |
|
166,486.6
|
235.7
|
L
 0.6%
H
234.3
237.0
|
L
 0.1%
H
231.1
240.4
|
L
 4.8%
H
224.1
241.3
|
L
 13.1%
H
207.7
241.3
|
L
 -1.1%
H
171.0
258.2
|
L
 -14.1%
H
171.0
281.7
|
L
 -0.6%
H
171.0
334.0
|
L
 265.9%
H
61.6
334.0
|
| Edwards Lifesciences |
|
48,907.7
|
84.3
|
L
 1.0%
H
83.7
84.4
|
L
 0.5%
H
81.3
85.2
|
L
 -1.6%
H
81.3
87.4
|
L
 11.9%
H
74.7
87.9
|
L
 20.8%
H
65.9
87.9
|
L
 6.3%
H
58.9
96.1
|
L
 -4.3%
H
58.9
131.7
|
L
 235.0%
H
25.1
131.7
|
| Glaukos Corp |
|
6,938.1
|
120.8
|
L
 -2.2%
H
119.7
122.5
|
L
 9.6%
H
94.0
124.4
|
L
 3.9%
H
94.0
124.4
|
L
 52.0%
H
73.2
124.4
|
L
 -22.8%
H
73.2
163.7
|
L
 148.9%
H
44.3
163.7
|
L
 34.3%
H
33.3
163.7
|
L
 643.8%
H
14.3
163.7
|
| Globus Medical Inc (Class A) |
|
12,489.9
|
93.3
|
L
 0.4%
H
93.3
94.4
|
L
 3.5%
H
89.2
94.7
|
L
 7.2%
H
85.7
101.4
|
L
 51.5%
H
59.5
101.4
|
L
 2.8%
H
51.8
101.4
|
L
 26.0%
H
43.4
101.4
|
L
 42.8%
H
43.4
101.4
|
L
 273.0%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,332.8
|
71.2
|
L
 1.6%
H
70.5
71.6
|
L
 -9.7%
H
70.0
78.9
|
L
 -11.2%
H
70.0
86.1
|
L
 40.4%
H
49.0
87.3
|
L
 -3.1%
H
47.3
87.3
|
L
 -20.3%
H
47.3
98.0
|
L
 -42.8%
H
43.5
142.1
|
L
 135.7%
H
26.0
142.1
|
| Herbalife Nutrition Ltd |
|
1,771.8
|
17.2
|
L
 1.3%
H
17.0
17.2
|
L
 9.9%
H
15.5
17.2
|
L
 22.6%
H
12.6
17.2
|
L
 99.0%
H
7.6
17.2
|
L
 161.0%
H
5.0
17.2
|
L
 -1.3%
H
5.0
21.3
|
L
 -66.4%
H
5.0
59
|
L
 -25.7%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
2,785.9
|
95.9
|
L
 1.5%
H
94.9
95.9
|
L
 3.7%
H
89.9
97.7
|
L
 -0.7%
H
89.9
102.6
|
L
 18.7%
H
71.5
147.0
|
L
 -46.0%
H
70.8
203.1
|
L
 -62.1%
H
70.8
330
|
L
 -56.7%
H
70.8
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,011.9
|
86.0
|
L
 1.0%
H
85.4
86.6
|
L
 3.9%
H
82.7
86.6
|
L
 9.4%
H
76.2
86.6
|
L
 -19.9%
H
62
112.0
|
L
 -39.0%
H
62
146.4
|
L
 15.8%
H
62
146.4
|
L
 8.7%
H
50.1
146.4
|
L
 130.0%
H
18.1
146.4
|
| McKesson |
|
99,949.7
|
809.8
|
L
 -1.5%
H
807
821.5
|
L
 -1.7%
H
807
847.9
|
L
 -1.3%
H
794.6
847.9
|
L
 2.8%
H
780.9
895.6
|
L
 36.7%
H
570.5
895.6
|
L
 114.2%
H
331.8
895.6
|
L
 339.7%
H
169.3
895.6
|
L
 376.3%
H
106.1
895.6
|
| Medtronic |
|
129,316.8
|
100.9
|
L
 2.3%
H
98.7
101.0
|
L
 4.6%
H
95.7
101.0
|
L
 2.3%
H
95.2
101.3
|
L
 5.2%
H
89.0
106.3
|
L
 14.5%
H
79.6
106.3
|
L
 24.7%
H
68.9
106.3
|
L
 -15.4%
H
68.9
135.9
|
L
 35.3%
H
68.9
135.9
|
| Mettler-Toledo International |
|
28,756.5
|
1,407.7
|
L
 0.3%
H
1407.7
1419.3
|
L
 -5.2%
H
1390.0
1502.5
|
L
 0.4%
H
1384.5
1514.4
|
L
 3.7%
H
1349.1
1525.2
|
L
 8.7%
H
946.7
1525.2
|
L
 -9.9%
H
928.5
1616.0
|
L
 10.9%
H
928.5
1714.8
|
L
 357.9%
H
291.3
1714.8
|
| Envista Holdings Corp |
|
4,058.0
|
24.7
|
L
 1.4%
H
24.5
24.8
|
L
 6.2%
H
23.0
25.4
|
L
 10.8%
H
21.6
25.4
|
L
 22.5%
H
18.8
25.4
|
L
 24.5%
H
14.2
25.4
|
L
 -33.0%
H
14.2
43.3
|
L
 -32.7%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
174.8
|
2.3
|
L
 2.7%
H
2.2
2.3
|
L
 -10.0%
H
2.2
2.7
|
L
 -20.4%
H
1.8
3.0
|
L
 -54.3%
H
1.8
5.6
|
L
 -84.5%
H
1.8
15.5
|
L
 -89.1%
H
1.8
28.4
|
L
 -91.7%
H
1.8
49.2
|
L
 -93.2%
H
1.8
49.2
|
| Penumbra Inc |
|
13,986.2
|
356.5
|
L
 0.3%
H
355.7
358
|
L
 18.5%
H
296.6
358
|
L
 12.9%
H
290
358
|
L
 44.0%
H
221.3
358
|
L
 35.2%
H
221.3
358
|
L
 43.6%
H
148
358
|
L
 46.8%
H
114.9
358
|
L
 666.2%
H
40.2
358
|
| Koninklijke Philips N.V. (ADR) |
|
27,616.4
|
29.0
|
L
 1.9%
H
29.0
29.1
|
L
 -2.0%
H
28.4
30.3
|
L
 8.9%
H
26.6
30.3
|
L
 2%
H
26.1
30.3
|
L
 12.6%
H
21.5
30.3
|
L
 75.8%
H
15.6
32.9
|
L
 -46.8%
H
11.8
61.2
|
L
 20.4%
H
11.8
61.2
|
| Qiagen NV |
|
11,134.2
|
54.1
|
L
 -2.5%
H
53.8
54.3
|
L
 14.5%
H
46.1
57.8
|
L
 12.7%
H
46.1
57.8
|
L
 5.5%
H
45.1
57.8
|
L
 8.5%
H
39.6
57.8
|
L
 -4.0%
H
38.8
57.8
|
L
 -10.1%
H
38.8
65.9
|
L
 110.6%
H
23.1
65.9
|
| Vicarious Surgical Inc (Class A) |
|
18.7
|
2.6
|
L
 2.3%
H
2.6
2.6
|
L
 -5.1%
H
2.5
3
|
L
 21.2%
H
1.8
3.3
|
L
 -56.9%
H
1.8
6.3
|
L
 -83.4%
H
1.8
16.9
|
L
 -99.9%
H
1.8
3199.5
|
L
 -100.0%
H
1.8
14207.0
|
L
H
1.8
14207.0
|
| ResMed |
|
37,138.2
|
254.4
|
L
 0.5%
H
253.5
255.4
|
L
 -0.1%
H
252.5
261.4
|
L
 3.9%
H
240
262.9
|
L
 -6.3%
H
237.6
270.8
|
L
 6.1%
H
199.9
293.8
|
L
 8.4%
H
132.2
293.8
|
L
 16.7%
H
132.2
301.3
|
L
 373.3%
H
53.3
301.3
|
| Steris PLC |
|
25,451.5
|
259.3
|
L
 0.5%
H
259.3
260.1
|
L
 -0.2%
H
256.5
269.4
|
L
 2.0%
H
246.7
269.4
|
L
 7.1%
H
232.2
269.4
|
L
 23.7%
H
204.9
269.4
|
L
 26.4%
H
173.2
269.4
|
L
 36.8%
H
159.2
269.4
|
L
 282.1%
H
61.4
269.4
|
| Stevanato Grp Spa |
|
5,214.4
|
19.1
|
L
H
19.1
19.1
|
L
 -6.4%
H
19.1
21.2
|
L
 -7.0%
H
19.1
22
|
L
 -26.1%
H
19.1
28.0
|
L
 -16.4%
H
17.8
28
|
L
 -2.6%
H
16.6
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
| Stryker |
|
139,584.6
|
365
|
L
 1.5%
H
360.9
365
|
L
 2.6%
H
350.0
365.4
|
L
 2.8%
H
344.6
370.9
|
L
 -4.3%
H
344.6
392.6
|
L
 -4.8%
H
329.2
406.2
|
L
 42.5%
H
249.0
406.2
|
L
 48.9%
H
188.8
406.2
|
L
 301.1%
H
90.3
406.2
|
| Smith & Nephew PLC (ADR) |
|
14,014.7
|
33.0
|
L
 2.6%
H
32.9
33.0
|
L
 3.5%
H
32.0
34.1
|
L
 0.6%
H
31.9
34.2
|
L
 -9.1%
H
31.8
37.5
|
L
 30.6%
H
23.9
38.8
|
L
 15.9%
H
21.5
38.8
|
L
 -28.0%
H
21.5
45.7
|
L
 4.9%
H
21.5
52.3
|
| Teleflex Incorporated |
|
4,521.5
|
102.3
|
L
 2.0%
H
101.2
102.5
|
L
 -1.5%
H
100.2
106.5
|
L
 -16.1%
H
100.2
127.5
|
L
 -21.6%
H
100.2
137.0
|
L
 -43.6%
H
100.2
185.9
|
L
 -56.6%
H
100.2
276.4
|
L
 -74.0%
H
100.2
449.4
|
L
 -22.8%
H
100.2
449.4
|
| Thermo Fisher |
|
233,262.1
|
620.9
|
L
 0.3%
H
620.4
625.7
|
L
 2.3%
H
606
629.9
|
L
 9.3%
H
565.8
629.9
|
L
 14.2%
H
550.9
629.9
|
L
 10.9%
H
385.5
629.9
|
L
 4.6%
H
385.5
629.9
|
L
 20.4%
H
385.5
672.3
|
L
 366.6%
H
119.8
672.3
|
| Waters |
|
22,940.7
|
385.3
|
L
 0.4%
H
383.0
387.3
|
L
 -2.2%
H
376.5
398.9
|
L
 1.9%
H
373.5
408.7
|
L
 12.3%
H
340.1
414.2
|
L
 -4.6%
H
275.1
423.6
|
L
 13.7%
H
231.9
423.6
|
L
 42.1%
H
231.9
428.2
|
L
 208.2%
H
112
428.2
|
| West Pharma Services |
|
17,674.3
|
245.7
|
L
 -1.9%
H
245.4
251.7
|
L
 -9.6%
H
245.4
281.6
|
L
 -9.9%
H
245.4
291.4
|
L
 -10.6%
H
245.4
322.3
|
L
 -27.0%
H
187.4
348.9
|
L
 -5.3%
H
187.4
415.7
|
L
 -19.5%
H
187.4
475.4
|
L
 322.0%
H
53.9
475.4
|
| Zimmer Biomet Holdings |
|
17,410.3
|
87.9
|
L
 1.2%
H
86.9
88.0
|
L
 -0.6%
H
85.8
90.3
|
L
 -1.4%
H
85.8
95.3
|
L
 -14.5%
H
85.3
106.9
|
L
 -19.8%
H
85.3
114.4
|
L
 -29.2%
H
85.3
149.3
|
L
 -42.9%
H
85.3
169.7
|
L
 -5.0%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
9,003.8
|
312.8
|
L
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 9.8%
H
303.2
321.1
|
L
 -8.3%
H
225.3
359.2
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
45,999.8
|
10.3
|
L
 2.0%
H
10.3
10.3
|
L
 5.2%
H
9.7
10.3
|
L
 4.3%
H
9.7
10.3
|
L
 9.8%
H
9.0
10.3
|
L
 11.8%
H
8.7
11.4
|
L
 28.8%
H
7.5
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
12,828.5
|
113.2
|
L
 1.1%
H
112.2
113.5
|
L
 2.7%
H
108.3
115.8
|
L
 17.6%
H
95.9
115.8
|
L
 18.7%
H
88.5
115.8
|
L
 -4.4%
H
81.4
128.3
|
L
 -17.9%
H
79.5
145.4
|
L
 -25.2%
H
79.5
203.2
|
L
 134.9%
H
39.5
203.2
|
| Aethlon Medical Inc |
|
2.6
|
2.7
|
L
 -0.4%
H
2.7
2.8
|
L
 4.7%
H
2.6
3.2
|
L
 -5.9%
H
2.2
3.2
|
L
 -51.2%
H
2.2
5.9
|
L
 -94.9%
H
2.2
64
|
L
 -99.3%
H
2.2
695.6
|
L
 -99.9%
H
2.2
9992
|
L
 -100.0%
H
2.2
109078.8
|
| Ainos Inc |
|
13.1
|
1.9
|
L
H
1.9
1.9
|
L
 -1.6%
H
1.9
2.0
|
L
 -10.9%
H
1.6
2.1
|
L
 -52.3%
H
1.6
4.0
|
L
 -39.9%
H
1.6
4.8
|
L
 -89.9%
H
1.6
45.8
|
L
 -97.4%
H
1.6
1781.3
|
L
 394.7%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
167.3
|
2.7
|
L
 -3.6%
H
2.7
2.8
|
L
 11.7%
H
2.2
3.0
|
L
 22.4%
H
1.8
3.0
|
L
 -74.1%
H
1.8
12
|
L
 -49.7%
H
1.5
12
|
L
 -46.6%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,069.1
|
168.2
|
L
 1.6%
H
167.3
168.6
|
L
 -1.2%
H
164.4
174.7
|
L
 6.7%
H
154.6
174.7
|
L
 24.7%
H
130.2
174.7
|
L
 -25.0%
H
122
237.2
|
L
 -30.8%
H
122
413.2
|
L
 -70.2%
H
122
737.5
|
L
 178.8%
H
57.5
737.5
|
| Angiodynamic Inc |
|
430.7
|
10.5
|
L
 0.9%
H
10.4
10.5
|
L
 3.8%
H
9.9
11.1
|
L
 -21.8%
H
9.7
13.9
|
L
 -11.6%
H
9.7
14.0
|
L
 -15.9%
H
8.3
14.0
|
L
 -21.5%
H
5.3
14.0
|
L
 -44.3%
H
5.3
32
|
L
 -8.2%
H
5.3
32
|
| Anika Therapeutics Inc |
|
137.3
|
9.5
|
L
 0.6%
H
9.5
9.5
|
L
 -0.3%
H
9.2
9.6
|
L
 -0.5%
H
9.2
9.9
|
L
 -1.4%
H
9.2
10.8
|
L
 -40.8%
H
7.9
18.4
|
L
 -69.2%
H
7.9
32.3
|
L
 -76.1%
H
7.9
48.4
|
L
 -74.1%
H
7.9
75.7
|
| Apyx Medical Corp |
|
160.0
|
3.9
|
L
 1.3%
H
3.9
3.9
|
L
 0.5%
H
3.7
4.1
|
L
 11.8%
H
3.4
4.1
|
L
 24.6%
H
2.8
4.4
|
L
 180.6%
H
0.8
4.4
|
L
 47.7%
H
0.8
8.0
|
L
 -63.1%
H
0.8
17.5
|
L
 78.9%
H
0.8
17.5
|
| Accuray Inc |
|
92.9
|
0.8
|
L
 1.2%
H
0.8
0.9
|
L
 -4.7%
H
0.8
0.9
|
L
 -9.9%
H
0.8
0.9
|
L
 -51.5%
H
0.8
1.7
|
L
 -63.4%
H
0.8
3.0
|
L
 -65.5%
H
0.8
4.3
|
L
 -84.8%
H
0.8
6.0
|
L
 -86.1%
H
0.8
6.4
|
| Alphatec Holdings Inc |
|
2,532.8
|
17.1
|
L
 -0.6%
H
17.0
17.2
|
L
 3.7%
H
15.4
18.0
|
L
 -14.8%
H
15.4
23.3
|
L
 10%
H
15.2
23.3
|
L
 47.4%
H
8.8
23.3
|
L
 26.8%
H
4.9
23.3
|
L
 14.7%
H
4.9
23.3
|
L
 383.0%
H
1.2
23.3
|
| Atricure Inc |
|
1,930.5
|
38.8
|
L
 1.1%
H
38.5
39.1
|
L
 6.7%
H
36.1
41.8
|
L
 -5.2%
H
36.1
43.2
|
L
 3.7%
H
30.9
43.2
|
L
 0.9%
H
28.3
43.2
|
L
 -8.5%
H
18.9
59.6
|
L
 -32.1%
H
18.9
89.2
|
L
 104.5%
H
13.4
89.2
|
| Axogen Inc |
|
1,476.8
|
32.0
|
L
 0.5%
H
32.0
32.3
|
L
 3.5%
H
30.0
32.3
|
L
 0.1%
H
30.0
34.7
|
L
 88.7%
H
16.8
34.7
|
L
 77%
H
9.2
34.7
|
L
 205.0%
H
3.5
34.7
|
L
 64.8%
H
3.5
34.7
|
L
 537.8%
H
3.5
56.9
|
| Bone Biologics Corp |
|
3.1
|
1.7
|
L
H
1.7
1.7
|
L
 6.1%
H
1.6
1.9
|
L
 -5.5%
H
1.4
2.4
|
L
 -30.2%
H
1.3
2.5
|
L
 -70.0%
H
1.3
7.7
|
L
 -99.6%
H
1.3
576.9
|
L
 -100.0%
H
1.3
21600
|
L
H
1.3
169920
|
| BioAffinity Tech Inc |
|
6.2
|
1.4
|
L
 4.6%
H
1.3
1.4
|
L
 9.6%
H
1.2
1.5
|
L
 10.5%
H
1.1
1.5
|
L
 -52.4%
H
1.1
3.0
|
L
 -93.2%
H
1.1
46.5
|
L
 -97.0%
H
1.1
119.7
|
L
H
1.1
466.5
|
L
H
1.1
466.5
|
| Bluejay Diagnostics Inc |
|
1.3
|
0.7
|
L
 1.4%
H
0.7
0.7
|
L
 7.6%
H
0.7
0.8
|
L
 -11.3%
H
0.6
0.8
|
L
 -72.6%
H
0.6
2.7
|
L
 -78.8%
H
0.6
10.2
|
L
 -99.1%
H
0.1
140.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
| Biolife Soln Inc |
|
1,199.8
|
24.9
|
L
 0.7%
H
24.8
24.9
|
L
 4.3%
H
23.6
25.1
|
L
 -0.6%
H
23.3
26.7
|
L
 -10.6%
H
23.3
29.6
|
L
 -4.7%
H
19.1
29.6
|
L
 1.9%
H
8.9
29.6
|
L
 -38.6%
H
8.9
60.7
|
L
 1428.8%
H
1.4
60.7
|
| Biomerica Inc |
|
7.7
|
2.6
|
L
H
2.5
2.7
|
L
 -5.5%
H
2.5
2.8
|
L
 10.8%
H
2.3
2.9
|
L
 -18.0%
H
2.1
3.2
|
L
 300%
H
0.4
4.9
|
L
 -11.7%
H
0.2
4.9
|
L
 -58.4%
H
0.2
8.2
|
L
 132.7%
H
0.2
23.4
|
| Bruker Corp |
|
7,683.7
|
50.6
|
L
 1.5%
H
50.2
50.7
|
L
 -0.6%
H
46.8
50.7
|
L
 8.8%
H
46.5
56.2
|
L
 32.7%
H
36.1
56.2
|
L
 -11.1%
H
28.5
61
|
L
 -28.4%
H
28.5
94.9
|
L
 -17.0%
H
28.5
94.9
|
L
 127.7%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
9.9
|
1.1
|
L
 -0.9%
H
1.1
1.1
|
L
 -5.9%
H
1.1
1.2
|
L
 -3.5%
H
1
1.3
|
L
 -31.5%
H
1.0
1.7
|
L
 -43.7%
H
1.0
2.6
|
L
 -63.2%
H
1.0
7.1
|
L
 -97.5%
H
1.0
132
|
L
 -100.0%
H
0.4
20040
|
| Biosig Tech Inc |
|
137.9
|
3.4
|
L
 -0.6%
H
3.4
3.5
|
L
 6.6%
H
3.1
3.7
|
L
 -10.8%
H
2.9
3.8
|
L
 -37.1%
H
2.9
5.6
|
L
 191.4%
H
0.4
14.1
|
L
 363.0%
H
0.1
14.1
|
L
 -26.4%
H
0.1
14.1
|
L
 27.5%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
519.7
|
7.8
|
L
 0.7%
H
7.8
7.8
|
L
 0.8%
H
7.6
8.0
|
L
 3.6%
H
7.1
8.2
|
L
 10.9%
H
6.5
8.3
|
L
 -22.7%
H
5.8
11.3
|
L
 244.9%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
446.0
|
22.8
|
L
 2.9%
H
22.6
22.8
|
L
 -4.5%
H
21.9
23.9
|
L
 33.1%
H
17.8
24.8
|
L
 43.4%
H
14.3
24.8
|
L
 122.6%
H
7.8
24.8
|
L
 1016.2%
H
1.4
24.8
|
L
 177.3%
H
1.4
24.8
|
L
H
1.4
24.8
|
| Cardio Diagnostics Holdings Inc |
|
3.1
|
1.7
|
L
 -2.9%
H
1.7
1.8
|
L
 -7.1%
H
1.6
1.9
|
L
 -47.4%
H
1.6
3.7
|
L
 -62.1%
H
1.6
4.6
|
L
 -89.3%
H
1.6
21.2
|
L
 -94.9%
H
1.6
255
|
L
H
1.6
307.5
|
L
H
1.6
307.5
|
| Caredx Inc |
|
1,024.0
|
19.9
|
L
 -1.4%
H
19.9
20.3
|
L
 -1.4%
H
19.5
21.2
|
L
 2.4%
H
16.9
21.2
|
L
 30.8%
H
14.0
21.2
|
L
 -7.1%
H
11.0
25.6
|
L
 38.9%
H
4.8
34.8
|
L
 -79.2%
H
4.8
96.9
|
L
 270.1%
H
0.8
99.8
|
| Celcuity Inc |
|
4,878.8
|
105.4
|
L
 0.1%
H
104.4
105.8
|
L
 1.2%
H
103
116.4
|
L
 4.2%
H
98.5
116.4
|
L
 49.4%
H
64.6
116.4
|
L
 864.7%
H
7.6
116.4
|
L
 833.1%
H
7.6
116.4
|
L
 619.2%
H
4.8
116.4
|
L
H
4.0
116.4
|
| Creative Medical Tech Holdings Inc |
|
7.0
|
2
|
L
 1.0%
H
2
2
|
L
 9.9%
H
1.7
2.1
|
L
 -5.2%
H
1.5
2.5
|
L
 -44.6%
H
1.5
6.3
|
L
 -11.9%
H
1.5
6.9
|
L
 -57.4%
H
1.5
14.2
|
L
 -98.1%
H
1.5
650
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
474.5
|
2.5
|
L
 -0.4%
H
2.5
2.5
|
L
 -2.0%
H
2.4
3.0
|
L
 18.2%
H
1.9
3.0
|
L
 51.5%
H
1.4
3.0
|
L
 38.0%
H
1.1
3.0
|
L
 -20.8%
H
1.1
3.5
|
L
 -66.1%
H
1.1
8.4
|
L
 -55.3%
H
1.1
8.9
|
| Check-Cap Ltd |
|
10.3
|
1.7
|
L
H
1.6
1.7
|
L
 -2.3%
H
1.6
1.8
|
L
 -10.1%
H
1.6
1.9
|
L
 7.6%
H
1.2
2.1
|
L
 30%
H
0.6
3.1
|
L
 -44.0%
H
0.6
5.9
|
L
 -94.9%
H
0.6
89.8
|
L
 -99.7%
H
0.6
173376
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
19.4
|
1.5
|
L
 3.4%
H
1.5
1.6
|
L
 -7.3%
H
1.5
1.7
|
L
H
1.3
1.7
|
L
 -39.0%
H
1.3
2.6
|
L
 -62.3%
H
1.3
5.0
|
L
 -84.9%
H
1.3
14.0
|
L
 -89.3%
H
1.3
24.3
|
L
 -93.7%
H
1.3
24.3
|
| ClearPoint Neuro Inc |
|
415.3
|
14.0
|
L
 0.4%
H
13.9
14.1
|
L
 -3.5%
H
13.6
15.5
|
L
 -1.7%
H
13.4
16.6
|
L
 -48.9%
H
12.3
27.3
|
L
 -7.2%
H
9.8
30.1
|
L
 39.9%
H
4.1
30.1
|
L
 -28.9%
H
4.1
31.3
|
L
 -12.8%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
189.3
|
2.8
|
L
H
2.8
2.8
|
L
 -2.1%
H
2.7
3.0
|
L
 9.3%
H
2.5
3.3
|
L
 23.3%
H
1.9
3.3
|
L
 -18.6%
H
1.9
5.0
|
L
 58.8%
H
0.9
6.4
|
L
 -74.8%
H
0.9
15.0
|
L
 -98.8%
H
0.7
499.0
|
| Castle Biosciences Inc |
|
1,202.6
|
41.2
|
L
 0.8%
H
40.9
41.9
|
L
 3.9%
H
39.2
41.9
|
L
 4.5%
H
37.3
42.2
|
L
 79.1%
H
22.7
42.2
|
L
 65.2%
H
14.6
42.2
|
L
 54.7%
H
9.3
42.2
|
L
 -49.4%
H
9.3
107.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
708.4
|
5.5
|
L
 4.3%
H
5.4
5.6
|
L
 -2.8%
H
5.2
5.7
|
L
 11.9%
H
4.9
6.0
|
L
 37.1%
H
3.7
6.2
|
L
 1.5%
H
2.4
6.2
|
L
 -49.7%
H
2.4
13.8
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
42.7
|
0.7
|
L
H
0.7
0.7
|
L
 -6.9%
H
0.7
0.7
|
L
 6.3%
H
0.6
0.8
|
L
 -20%
H
0.6
0.9
|
L
 -34.0%
H
0.6
1.6
|
L
 -67.6%
H
0.6
4.6
|
L
 -92.6%
H
0.6
11.7
|
L
 -83.5%
H
0.6
15.0
|
| Citius Pharma Inc |
|
16.4
|
0.8
|
L
 -2.5%
H
0.8
0.8
|
L
 -8.1%
H
0.7
0.9
|
L
 -26.2%
H
0.6
1.2
|
L
 -56.4%
H
0.6
2.0
|
L
 -76.1%
H
0.6
3.4
|
L
 -97.7%
H
0.1
42.8
|
L
 -97.6%
H
0.1
114
|
L
 -99.9%
H
0.1
937.5
|
| CVRx Inc |
|
146.3
|
5.6
|
L
 -0.2%
H
5.6
5.7
|
L
 -8.7%
H
5.1
6.1
|
L
 -30.5%
H
5.1
8.7
|
L
 -44.7%
H
5.1
11.3
|
L
 -68.3%
H
4.3
18.6
|
L
 -62.6%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
355.3
|
10.2
|
L
 0.5%
H
10.2
10.3
|
L
 -1.7%
H
10.1
10.6
|
L
 1.8%
H
9.7
10.9
|
L
 -10.3%
H
8.1
11.5
|
L
 -28.4%
H
8.1
18.2
|
L
 173.1%
H
2.3
18.2
|
L
 -39.7%
H
2.3
25.2
|
L
 -100.0%
H
2.3
921200000
|
| Alpha Tau Medical Ltd |
|
576.4
|
6.8
|
L
 4.6%
H
6.6
6.8
|
L
 3.1%
H
6.2
7.9
|
L
 33.3%
H
4.8
7.9
|
L
 69%
H
3.4
7.9
|
L
 72.9%
H
2.3
7.9
|
L
 57.2%
H
1.8
7.9
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
27,738.0
|
71.1
|
L
 0.6%
H
71
71.7
|
L
 1.2%
H
68.5
71.7
|
L
 7.7%
H
65.2
72.5
|
L
 3.9%
H
54.1
72.5
|
L
 -15.7%
H
54.1
93.2
|
L
 -34.1%
H
54.1
142
|
L
 -21.9%
H
54.1
164.9
|
L
 284.2%
H
10.7
164.9
|
| Daxor Corp |
|
67.9
|
13.5
|
L
H
13.5
13.5
|
L
 -3.0%
H
13.0
13.9
|
L
 4.4%
H
12
14.8
|
L
 1.4%
H
11.4
14.8
|
L
 58.5%
H
6.6
14.8
|
L
 49.5%
H
6.6
14.8
|
L
 1.4%
H
6.6
17.6
|
L
 75.4%
H
3.4
24.1
|
| ElectroCore Inc |
|
55.1
|
6.9
|
L
 0.2%
H
6.9
7.2
|
L
 9.5%
H
5.6
7.5
|
L
 49.8%
H
4.4
7.5
|
L
 37.0%
H
4.4
7.5
|
L
 -56.7%
H
4.2
19.5
|
L
 20.9%
H
3.1
19.5
|
L
 -81.5%
H
2.9
54.5
|
L
H
2.9
303.8
|
| Ekso Bionics Holdings Inc |
|
22.3
|
8.5
|
L
 3.3%
H
8.4
8.5
|
L
 3.3%
H
7.7
9.1
|
L
 74.7%
H
4.8
12.7
|
L
 75.4%
H
3.5
12.7
|
L
 -94.2%
H
2.7
155.3
|
L
 -97.8%
H
2.7
704.0
|
L
 -99.6%
H
2.7
3370.5
|
L
 -100.0%
H
2.7
24232.5
|
| Embecta Corp |
|
734.2
|
12.4
|
L
 0.9%
H
12.3
12.4
|
L
 -2.1%
H
12.0
12.9
|
L
 5.5%
H
11.4
13.0
|
L
 -12.1%
H
11.0
14.9
|
L
 -33.6%
H
9.2
19.7
|
L
 -47.7%
H
9.2
33.9
|
L
H
9.2
63
|
L
H
9.2
63
|
| Establishment Labs Holdings Inc |
|
1,905.0
|
65.6
|
L
 1.4%
H
64.8
65.6
|
L
 0.7%
H
63.3
69.0
|
L
 -11.9%
H
63.3
77.5
|
L
 32.9%
H
47
78.2
|
L
 89.7%
H
26.6
78.2
|
L
 -4.6%
H
17
79.9
|
L
 36.2%
H
17
93.8
|
L
H
7.6
93.8
|
| Exact Sciences Corp |
|
19,434.2
|
102.3
|
L
 0.0%
H
102.3
102.4
|
L
 0.1%
H
102
102.6
|
L
 0.5%
H
101.4
102.6
|
L
 63.1%
H
62.4
102.7
|
L
 97.8%
H
38.8
102.7
|
L
 50.0%
H
38.8
102.7
|
L
 -31.9%
H
29.3
159.5
|
L
 1534.7%
H
4.7
159.5
|
| EDAP TMS S.A. (ADR) |
|
133.9
|
3.6
|
L
 -3.0%
H
3.6
3.7
|
L
 -12.5%
H
3.4
4.2
|
L
 21.8%
H
2.7
4.2
|
L
 51.1%
H
1.8
4.2
|
L
 65.0%
H
1.2
4.2
|
L
 -66.9%
H
1.2
12.7
|
L
 -56.6%
H
1.2
12.7
|
L
 5.9%
H
1.2
12.7
|
| GlucoTrack Inc |
|
3.1
|
3.4
|
L
 -10.5%
H
3.4
3.6
|
L
 -6.6%
H
3.4
4.2
|
L
 -28.3%
H
3.2
4.8
|
L
 -50.8%
H
3.2
7.5
|
L
 -96.7%
H
3.2
169.2
|
L
 -100.0%
H
3.2
22500
|
L
 -100.0%
H
3.2
46800
|
L
 -100.0%
H
3.2
468000
|
| GE HealthCare Tech |
|
36,214.0
|
79.5
|
L
 0.9%
H
79.4
80
|
L
 -6.2%
H
78.3
85.4
|
L
 -4.1%
H
78.3
89.8
|
L
 5.3%
H
70.0
89.8
|
L
 -6.2%
H
57.7
94.8
|
L
 19.1%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
25.9
|
0.6
|
L
H
0.6
0.6
|
L
 -1.7%
H
0.6
0.6
|
L
 -22.7%
H
0.6
0.8
|
L
 45%
H
0.4
0.9
|
L
 -70.0%
H
0.3
2.0
|
L
 -79.9%
H
0.3
6.3
|
L
 -86.4%
H
0.3
8.8
|
L
 -78.8%
H
0.3
8.8
|
| Hologic |
|
16,756.7
|
75.1
|
L
 0.0%
H
75.0
75.2
|
L
 0.3%
H
74.9
75.2
|
L
 0.2%
H
74.2
75.2
|
L
 4.5%
H
73.9
75.3
|
L
 7.7%
H
51.9
75.3
|
L
 -5.7%
H
51.9
87.9
|
L
 -2.7%
H
51.9
87.9
|
L
 115.9%
H
26.5
87.9
|
| Heart Test Laboratories Inc |
|
11.4
|
3.6
|
L
 -1.1%
H
3.6
3.6
|
L
 18.8%
H
3.1
3.7
|
L
 52.5%
H
2.3
3.7
|
L
 4.7%
H
2.0
3.7
|
L
 3.8%
H
2.0
6.5
|
L
 -95.5%
H
2.0
395
|
L
H
2.0
600
|
L
H
2.0
600
|
| Helius Medical Tech Inc (Class A) |
|
126.0
|
3.1
|
L
 0.3%
H
3.0
3.1
|
L
 -11.6%
H
3.0
3.7
|
L
 2.4%
H
2.6
3.7
|
L
 -55.6%
H
2.6
7.2
|
L
 -99.5%
H
2.6
1200
|
L
 -100.0%
H
2.6
15732.2
|
L
 -100.0%
H
2.6
786750
|
L
 -100.0%
H
2.6
27168750
|
| Henry Schein |
|
9,169.6
|
77.9
|
L
 0.2%
H
77.7
78.3
|
L
 2.7%
H
74.9
80.1
|
L
 0.7%
H
74.1
80.1
|
L
 21.8%
H
62.1
80.1
|
L
 6.4%
H
60.6
82.5
|
L
 -3.7%
H
60.0
89.7
|
L
 11.0%
H
60.0
92.7
|
L
 35.7%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
117.6
|
1.2
|
L
 0.8%
H
1.2
1.2
|
L
 6.1%
H
1.1
1.3
|
L
 10%
H
0.9
1.3
|
L
 -6.9%
H
0.9
1.3
|
L
 23.5%
H
0.5
2.2
|
L
 27.4%
H
0.5
3.3
|
L
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
948.7
|
12.2
|
L
 1.4%
H
12.1
12.2
|
L
 -1.3%
H
11.8
13.0
|
L
 -3.7%
H
11.8
14.1
|
L
 -22.4%
H
10.9
16.5
|
L
 -49.5%
H
10.9
27.1
|
L
 -78.4%
H
10.9
60.7
|
L
 -82.6%
H
10.9
77.4
|
L
 -61.4%
H
10.9
77.4
|
| Icecure Medical Ltd |
|
44.1
|
0.6
|
L
H
0.6
0.7
|
L
 -3.0%
H
0.6
0.7
|
L
 -5.9%
H
0.6
0.7
|
L
 -25.6%
H
0.6
0.9
|
L
 -47.5%
H
0.6
1.7
|
L
 -49.6%
H
0.5
1.7
|
L
 -65.2%
H
0.5
16
|
L
 -44.3%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
8.8
|
2.3
|
L
 1.8%
H
2.3
2.3
|
L
 -19.2%
H
2.3
3.0
|
L
 -90.5%
H
2.2
27.9
|
L
 -96.3%
H
2.2
64.8
|
L
 -98.7%
H
2.2
307
|
L
 -100.0%
H
2.2
14775
|
L
H
2.2
55000
|
L
H
2.2
55000
|
| ICU Medical Inc |
|
3,824.5
|
154.9
|
L
 1.1%
H
154.4
154.9
|
L
 4.5%
H
146.3
157.9
|
L
 6.7%
H
137.4
157.9
|
L
 32.0%
H
115
157.9
|
L
 -5.5%
H
107
175.5
|
L
 -17.2%
H
78.4
212.4
|
L
 -28.9%
H
78.4
282
|
L
 60.9%
H
78.4
321.7
|
| Idexx Laboratories |
|
54,519.3
|
682.8
|
L
 -0.5%
H
681
690.0
|
L
 -4.4%
H
681
719.9
|
L
 -2.5%
H
661.9
726.4
|
L
 6.1%
H
622.1
770.0
|
L
 62.9%
H
356.3
770.0
|
L
 39.7%
H
356.3
770.0
|
L
 37.9%
H
317.1
770.0
|
L
 927.8%
H
63.5
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
29.1
|
0.8
|
L
 -1.2%
H
0.8
0.9
|
L
 -12.9%
H
0.8
1.0
|
L
 -20.6%
H
0.8
1.1
|
L
 -28.3%
H
0.8
1.2
|
L
 -23.6%
H
0.4
1.7
|
L
 -35.2%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
| Intercure Ltd |
|
51.9
|
1.0
|
L
 2.2%
H
0.9
1.0
|
L
 1.1%
H
0.9
1.0
|
L
 -30.2%
H
0.7
1.3
|
L
 -39.1%
H
0.7
1.5
|
L
 -44.1%
H
0.7
1.8
|
L
 -75.3%
H
0.7
4.0
|
L
 -82.9%
H
0.7
12.7
|
L
H
0.7
19.4
|
| Inogen Inc |
|
173.2
|
6.4
|
L
 2.7%
H
6.2
6.4
|
L
 2.6%
H
6.1
6.5
|
L
 -4.9%
H
6
7.5
|
L
 -25.6%
H
6
9.1
|
L
 -39.1%
H
5.7
12.9
|
L
 -71.8%
H
4.1
26.1
|
L
 -86.1%
H
4.1
82.4
|
L
 -82.3%
H
4.1
287.8
|
| Inmode Ltd |
|
879.2
|
13.9
|
L
 0.7%
H
13.9
14.0
|
L
 -0.9%
H
13.7
14.2
|
L
 -3.1%
H
13.7
15.7
|
L
 -13.1%
H
13.7
16.3
|
L
 -17.2%
H
13.1
19.8
|
L
 -59.5%
H
13.1
48.3
|
L
 -53.6%
H
13.1
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
28.6
|
1.9
|
L
 -20.3%
H
1.9
2.3
|
L
 136.3%
H
0.8
4.6
|
L
 105.4%
H
0.7
4.6
|
L
 -65.3%
H
0.7
5.8
|
L
 -98.7%
H
0.7
148.2
|
L
 -99.9%
H
0.7
4721.5
|
L
 -100.0%
H
0.7
70848
|
L
 -100.0%
H
0.7
141926.4
|
| IRIDEX Corp |
|
26.1
|
1.5
|
L
 2.7%
H
1.5
1.5
|
L
 10.1%
H
1.3
1.5
|
L
 52%
H
1
1.5
|
L
 43.4%
H
0.9
1.5
|
L
 -8.4%
H
0.8
1.7
|
L
 -33.0%
H
0.8
3.7
|
L
 -72.3%
H
0.8
9.7
|
L
 -83.2%
H
0.8
16.6
|
| Iradimed Corp |
|
1,319.8
|
103.8
|
L
 0.8%
H
103.8
103.8
|
L
 4.5%
H
97.6
103.8
|
L
 6.8%
H
90.9
103.8
|
L
 38.9%
H
74.0
103.8
|
L
 75.3%
H
47.5
103.8
|
L
 196.4%
H
33.5
103.8
|
L
 347.6%
H
21.7
103.8
|
L
 375.7%
H
7.9
103.8
|
| iRhythm Tech Inc |
|
5,266.5
|
163.5
|
L
 -1.3%
H
163.5
166.7
|
L
 5.2%
H
153.8
174.4
|
L
 -6.2%
H
149.9
191.4
|
L
 -10.3%
H
149.9
212
|
L
 50.9%
H
92.5
212
|
L
 63.6%
H
55.9
212
|
L
 -39.1%
H
41.7
286.2
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
186,592.6
|
526.4
|
L
 -0.2%
H
523.9
530.1
|
L
 -6.3%
H
523.9
553.7
|
L
 -8.1%
H
523.9
603.9
|
L
 14.8%
H
456.3
603.9
|
L
 -11.2%
H
425
616
|
L
 105.0%
H
222.7
616
|
L
 97.7%
H
180.1
616
|
L
 754.2%
H
55.8
616
|
| Jowell Global Ltd |
|
4.7
|
2.2
|
L
H
2.2
2.2
|
L
 0.5%
H
2.0
2.2
|
L
 -8.5%
H
2.0
2.4
|
L
 25.7%
H
1.5
2.5
|
L
 -29.5%
H
1.5
3.2
|
L
 -74.9%
H
1
9.1
|
L
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
110.9
|
38.7
|
L
H
38.7
39.9
|
L
 4.0%
H
37.2
41.2
|
L
 1.1%
H
37.1
41.2
|
L
 -15.0%
H
37.0
46.6
|
L
 -37.6%
H
30.3
71.3
|
L
 130.2%
H
14.6
71.3
|
L
 195.6%
H
11.4
71.3
|
L
 129.1%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
483.2
|
19.3
|
L
 4.4%
H
18.5
19.3
|
L
 3.1%
H
17.9
19.7
|
L
 12.9%
H
16.9
20.3
|
L
 9.4%
H
15.9
20.3
|
L
 -29.1%
H
15.3
27.6
|
L
 -59.0%
H
15.3
53.5
|
L
 -54.7%
H
15.3
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
261.7
|
5.7
|
L
 1.3%
H
5.6
5.7
|
L
 -2.3%
H
5.4
5.9
|
L
 -2.6%
H
5.1
6.6
|
L
 36.5%
H
3.7
6.6
|
L
 38.1%
H
1.9
6.6
|
L
 45.2%
H
1.9
6.6
|
L
 9.9%
H
1.8
6.6
|
L
 1312.5%
H
0.3
12.8
|
| Standard BioTools Inc |
|
596.1
|
1.6
|
L
 2.7%
H
1.5
1.6
|
L
 -4.9%
H
1.5
1.7
|
L
 -4.9%
H
1.2
1.7
|
L
 21.1%
H
1.1
1.7
|
L
 -12.4%
H
0.9
1.9
|
L
 -21.3%
H
0.9
3.2
|
L
 -73.5%
H
0.9
7.5
|
L
 -75.1%
H
0.9
14.9
|
| LivaNova PLC |
|
3,466.9
|
63.5
|
L
 0.9%
H
62.9
63.5
|
L
 3.5%
H
60.4
64.1
|
L
 1.1%
H
60.4
65.4
|
L
 17.4%
H
48.8
65.6
|
L
 31.5%
H
32.5
65.6
|
L
 11.7%
H
32.5
65.6
|
L
 -1.5%
H
32.5
93.9
|
L
 18.7%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,955.3
|
86.2
|
L
 0.5%
H
86.2
86.2
|
L
 3.4%
H
81.9
88.4
|
L
 1.5%
H
79.4
88.4
|
L
 -2.1%
H
79.4
92.3
|
L
 -13.0%
H
71.4
105.6
|
L
 82.8%
H
44.3
109.6
|
L
 91.9%
H
38.3
109.6
|
L
 464.4%
H
12.0
109.6
|
| LENSAR Inc |
|
143.3
|
12
|
L
H
11.9
12.0
|
L
 2.3%
H
11.7
12.1
|
L
 -0.1%
H
11.2
12.2
|
L
 -2.3%
H
9.5
12.7
|
L
 44.2%
H
8.1
17.3
|
L
 341.2%
H
1.8
17.3
|
L
 89.9%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
4,389.8
|
66.2
|
L
 0.5%
H
66.2
66.3
|
L
 0.6%
H
63.4
67
|
L
 0.4%
H
63.4
70.3
|
L
 17.0%
H
50.2
70.3
|
L
 -27.6%
H
47.3
111.3
|
L
 23.9%
H
47.3
126.9
|
L
 330.4%
H
15.3
126.9
|
L
 2624.3%
H
1.8
126.9
|
| Lucid Diagnostics Inc |
|
201.9
|
1.5
|
L
 27.3%
H
1.5
1.6
|
L
 29.4%
H
1.2
1.6
|
L
 37.5%
H
1.0
1.6
|
L
 23.2%
H
1.0
1.6
|
L
 83.3%
H
0.8
1.8
|
L
 16.7%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
75.9
|
1.8
|
L
 4.0%
H
1.8
1.9
|
L
 -5.6%
H
1.7
2.0
|
L
 -29.2%
H
1.7
2.6
|
L
 10.2%
H
1.3
2.9
|
L
 -70.6%
H
1.3
9.4
|
L
 -78.8%
H
1.3
14.8
|
L
 -97.0%
H
1.3
68.8
|
L
H
1.3
69.5
|
| Masimo Corp |
|
7,738.0
|
144.1
|
L
 1.0%
H
143.6
145.0
|
L
 11.0%
H
128.9
145.0
|
L
 7.5%
H
125.9
145.0
|
L
 -2.0%
H
125.9
157.7
|
L
 -16.4%
H
125.9
194.9
|
L
 -14.5%
H
75.2
198
|
L
 -45.3%
H
75.2
305.2
|
L
 286.2%
H
33.0
305.2
|
| 908 Devices Inc |
|
235.3
|
6.5
|
L
 -0.3%
H
6.4
6.5
|
L
 21.0%
H
5.4
6.9
|
L
 11.3%
H
5.0
6.9
|
L
 -27.7%
H
5.0
9.2
|
L
 118.1%
H
1.9
9.3
|
L
 -29.2%
H
1.8
12.5
|
L
 -90.1%
H
1.8
79.6
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
790.9
|
5.3
|
L
 -0.9%
H
5.3
5.4
|
L
 -9.2%
H
5.1
5.9
|
L
 -24.3%
H
5.1
7.2
|
L
 -20.9%
H
5.1
8.0
|
L
 -41.5%
H
5.1
9.4
|
L
 56.6%
H
3.1
10.1
|
L
 -40.3%
H
2.4
16.0
|
L
 -36.8%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
464.3
|
84.1
|
L
 1.5%
H
84.1
84.1
|
L
 -0.3%
H
82.3
89.4
|
L
 3.8%
H
77.0
90.0
|
L
 10.0%
H
69.5
90.0
|
L
 -39.8%
H
55.5
155.1
|
L
 -57.3%
H
55.5
206.4
|
L
 -71.3%
H
55.5
333.4
|
L
 -5.9%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,902.7
|
82.7
|
L
 1.2%
H
82
82.8
|
L
 2.0%
H
79.7
82.8
|
L
 -5.7%
H
79.7
94.8
|
L
 -0.6%
H
79.7
94.8
|
L
 -19.6%
H
78.1
111.5
|
L
 17.7%
H
62.6
111.5
|
L
 44.2%
H
50.5
111.5
|
L
 404.2%
H
15.6
111.5
|
| Modular Medical Inc |
|
36.5
|
0.5
|
L
H
0.5
0.5
|
L
 -2.1%
H
0.5
0.5
|
L
 38.2%
H
0.3
0.5
|
L
 -23.0%
H
0.3
0.6
|
L
 -61.2%
H
0.3
1.4
|
L
 -83.3%
H
0.3
3.8
|
L
 -97.4%
H
0.3
19.5
|
L
 -42.0%
H
0.3
19.5
|
| Myriad Genetics Inc |
|
531.3
|
5.7
|
L
 0.4%
H
5.6
5.7
|
L
 -8.1%
H
5.5
6.2
|
L
 -13.0%
H
5.5
7.2
|
L
 -27.9%
H
5.5
8.5
|
L
 -54%
H
3.8
15.5
|
L
 -72.0%
H
3.8
29.3
|
L
 -79.3%
H
3.8
37.0
|
L
 -85.8%
H
3.8
50.4
|
| MDxHealth SA (ADR) |
|
-
|
3.7
|
L
 2.2%
H
3.6
3.7
|
L
 1.4%
H
3.5
4.0
|
L
 16.2%
H
3
4.0
|
L
 -11.6%
H
2.8
5.3
|
L
 86.7%
H
1.4
5.3
|
L
 -45.0%
H
1.4
7.6
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| ENvue Medical Inc |
|
1.3
|
1.2
|
L
 -1.6%
H
1.2
1.3
|
L
 -47.8%
H
1.1
2
|
L
 -59.7%
H
1.1
3.2
|
L
 -79.7%
H
1.1
6
|
L
 -97.8%
H
0.7
162.5
|
L
 -99.8%
H
0.7
836
|
L
 -99.9%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
5.6
|
4.8
|
L
 1.5%
H
4.6
4.8
|
L
 2.4%
H
4.3
4.8
|
L
 -7.0%
H
4.2
5.3
|
L
 -24.1%
H
4.1
7.0
|
L
 -20.1%
H
2.9
12.0
|
L
 -97.9%
H
0.0
234
|
L
 -99.8%
H
0.0
3100
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,038.2
|
9.4
|
L
 0.2%
H
9.3
9.5
|
L
 2.0%
H
8.9
9.8
|
L
 30.1%
H
6.9
10.3
|
L
 59.1%
H
5.4
10.3
|
L
 -18.9%
H
3.9
12.1
|
L
 -52.2%
H
3.9
24.1
|
L
 -78.1%
H
3.9
48.9
|
L
 -52.1%
H
3.9
48.9
|
| Nephros Inc |
|
51.1
|
4.8
|
L
 -2.6%
H
4.8
5.0
|
L
 8.8%
H
4.2
5.1
|
L
 -4.4%
H
4.2
5.5
|
L
 -8.2%
H
3.7
6.4
|
L
 200.6%
H
1.4
6.4
|
L
 259.0%
H
1.0
6.4
|
L
 -39.3%
H
0.9
11.7
|
L
 33.6%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
46.4
|
0.9
|
L
 2.2%
H
0.9
0.9
|
L
 3.4%
H
0.9
0.9
|
L
 26.0%
H
0.7
1.0
|
L
 10.8%
H
0.6
1.0
|
L
 -12.4%
H
0.4
1.4
|
L
 -30.3%
H
0.4
2.2
|
L
 -87.4%
H
0.4
13.5
|
L
H
0.4
30
|
| Nano X Imaging Ltd |
|
198.1
|
3.0
|
L
 1.3%
H
3
3.1
|
L
 -0.3%
H
2.9
3.2
|
L
 1.3%
H
2.8
3.2
|
L
 -28.2%
H
2.8
4.7
|
L
 -64.0%
H
2.8
9.2
|
L
 -65.9%
H
2.8
22.7
|
L
 -94.2%
H
2.8
94.8
|
L
H
2.8
94.8
|
| NeuroPace Inc |
|
552.2
|
16.6
|
L
 0.4%
H
16.6
16.8
|
L
 2.8%
H
15.7
17.6
|
L
 -0.1%
H
15.0
17.9
|
L
 54.4%
H
9.2
17.9
|
L
 38.5%
H
7.6
19.0
|
L
 456.4%
H
2.9
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
73.3
|
1.7
|
L
 7.5%
H
1.6
1.7
|
L
 9.5%
H
1.5
1.7
|
L
 -13.1%
H
1.5
2.2
|
L
 -26.1%
H
1.5
2.4
|
L
 -36.4%
H
1.5
3.8
|
L
 54.5%
H
1.0
3.9
|
L
 -83.8%
H
0.8
22.2
|
L
 -100.0%
H
0.8
622059.4
|
| Nortech Systems Inc |
|
23.3
|
8.4
|
L
H
8.2
8.4
|
L
 6.1%
H
7.9
8.8
|
L
 18.0%
H
7.1
8.8
|
L
 -14.2%
H
6.5
10
|
L
 -18.6%
H
6.5
12.4
|
L
 -37.6%
H
6.5
19.2
|
L
 7.0%
H
5.5
19.6
|
L
 112.2%
H
1.7
19.6
|
| Natera Inc |
|
32,813.8
|
235.3
|
L
 0.2%
H
234.0
237.6
|
L
 -1.1%
H
226.7
243.0
|
L
 1.4%
H
225.8
256.4
|
L
 24.8%
H
182.2
256.4
|
L
 48.6%
H
125.4
256.4
|
L
 475.2%
H
36.9
256.4
|
L
 90.7%
H
26.1
256.4
|
L
 2586.2%
H
6.5
256.4
|
| Nutriband Inc |
|
56.4
|
4.6
|
L
 0.7%
H
4.6
4.6
|
L
 9.2%
H
4.2
4.7
|
L
 3.1%
H
4.2
6.4
|
L
 -36.1%
H
4.2
8.3
|
L
 12.7%
H
4.0
11.8
|
L
 34.2%
H
1.5
11.8
|
L
 -65.7%
H
0.9
27.4
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.7
|
1.9
|
L
 3.8%
H
1.9
1.9
|
L
 -3.6%
H
1.7
2.9
|
L
 -12.0%
H
1.7
2.9
|
L
 -45.1%
H
1.7
4
|
L
 -96.3%
H
1.7
70.1
|
L
 -100.0%
H
1.7
16008.3
|
L
 -100.0%
H
1.7
1819771.8
|
L
 -100.0%
H
1.7
10000000000
|
| NovoCure Ltd |
|
1,468.1
|
13.1
|
L
 0.7%
H
13.1
13.1
|
L
 -4.0%
H
12.8
14.1
|
L
 2.1%
H
12.8
15.2
|
L
 -9.5%
H
10.7
15.2
|
L
 -49.9%
H
10.7
27.5
|
L
 -85.2%
H
10.7
95.9
|
L
 -92.4%
H
10.7
232.8
|
L
 -7.9%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.5
|
11.4
|
L
 -2.2%
H
11.1
11.5
|
L
 -2.6%
H
10.7
13.2
|
L
 1.7%
H
10.7
13.8
|
L
 -57.9%
H
10.5
27.5
|
L
 -90.1%
H
10.5
196.7
|
L
 -93.3%
H
10.5
244.0
|
L
 -96.3%
H
10.5
398.3
|
L
H
10.5
4935
|
| Nexalin Tech Inc |
|
12.3
|
0.7
|
L
 4.8%
H
0.6
0.7
|
L
 -2.9%
H
0.6
0.8
|
L
 -20.5%
H
0.5
0.8
|
L
 -60.7%
H
0.5
1.7
|
L
 -79.1%
H
0.5
3.9
|
L
 -42.1%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
203.5
|
4.7
|
L
H
4.7
4.9
|
L
 -9.6%
H
4.7
5.3
|
L
 -2.5%
H
4.5
5.4
|
L
 -19.4%
H
4.4
6.0
|
L
 -56.7%
H
4.3
11.9
|
L
 -15.5%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
| Nanobiotix (ADR) |
|
1,001.6
|
20.7
|
L
 -1.4%
H
20.7
20.9
|
L
 -3.2%
H
20.6
22.2
|
L
 -6.5%
H
19.6
24.0
|
L
 -15.6%
H
14.8
24.0
|
L
 583.2%
H
3.0
30.4
|
L
 373.7%
H
1.8
30.4
|
L
 5.2%
H
1.8
30.4
|
L
H
1.8
30.4
|
| Orchestra BioMed Holdings Inc |
|
229.8
|
4.1
|
L
 0.7%
H
4.1
4.1
|
L
 -4.9%
H
3.9
4.5
|
L
 -6.4%
H
3.9
5
|
L
 4.4%
H
3.5
5.4
|
L
 -22.9%
H
2.2
6.2
|
L
 -59.6%
H
2.2
23.4
|
L
 -67.6%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
540.1
|
13.6
|
L
H
13.6
13.9
|
L
 -7.9%
H
13.3
14.7
|
L
 -11.8%
H
13.3
16.4
|
L
 -12.7%
H
13.3
17.0
|
L
 -24.8%
H
10.2
20.5
|
L
 -33.4%
H
9.6
22.6
|
L
 -69.2%
H
9.6
48.5
|
L
 -65.8%
H
9.6
74.4
|
| Outset Medical Inc |
|
92.0
|
5.1
|
L
 0.4%
H
5.1
5.1
|
L
 -1.0%
H
5.0
5.7
|
L
 37.0%
H
3.1
6.5
|
L
 -67.4%
H
3.1
15.9
|
L
 -57.2%
H
0.5
22.0
|
L
 -98.8%
H
0.5
458.3
|
L
 -99.3%
H
0.5
915
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
470.8
|
3.7
|
L
H
3.7
3.8
|
L
 -9.1%
H
3.6
4.0
|
L
 -33.8%
H
3.6
5.9
|
L
 -9.1%
H
3.6
7.1
|
L
 11.1%
H
2.6
7.1
|
L
 42.1%
H
1.8
7.1
|
L
 -65.8%
H
1.8
24.3
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
187.2
|
2.6
|
L
 0.8%
H
2.6
2.6
|
L
 0.4%
H
2.6
2.8
|
L
 9.2%
H
2.3
2.8
|
L
 -14.1%
H
2.1
3.1
|
L
 -28.5%
H
2.1
4.2
|
L
 -48.1%
H
2.1
8.5
|
L
 -80.4%
H
2.1
15.9
|
L
 -53.5%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
697.4
|
2.3
|
L
 -2.1%
H
2.3
2.4
|
L
 8.5%
H
2.1
2.4
|
L
 25.5%
H
1.7
2.4
|
L
 16.7%
H
1.5
2.7
|
L
 40.9%
H
0.9
2.7
|
L
 -79.5%
H
0.9
14.6
|
L
 -94.0%
H
0.9
53.7
|
L
 -81.2%
H
0.9
53.7
|
| PAVmed Inc |
|
20.8
|
22.6
|
L
 264.5%
H
17.6
22.6
|
L
 172.1%
H
6.1
22.6
|
L
 144.2%
H
6
22.6
|
L
 47.7%
H
6
22.6
|
L
 15.7%
H
6
26.9
|
L
 -89.0%
H
6
280.8
|
L
 -97.6%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
135.0
|
41.4
|
L
 -0.8%
H
41.4
41.4
|
L
 2.6%
H
39.8
43.4
|
L
 7.0%
H
36.6
47.4
|
L
 61.5%
H
25.3
47.4
|
L
 -6.7%
H
23.5
70.3
|
L
 141.8%
H
14.5
70.3
|
L
 33.4%
H
12.4
70.3
|
L
 1748.2%
H
2.3
70.3
|
| Pulse Biosciences Inc |
|
947.4
|
14.0
|
L
 1.1%
H
13.9
14.0
|
L
 -1.2%
H
13.8
14.8
|
L
 -8.4%
H
13.2
16.0
|
L
 -23.2%
H
12.6
18.4
|
L
 -20.6%
H
12.6
25
|
L
 390.5%
H
2.4
25
|
L
 -51.8%
H
1.2
45.8
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
20.4
|
6
|
L
 0.2%
H
6.0
6.4
|
L
 -16.8%
H
5.3
9
|
L
 -11.5%
H
5.3
9
|
L
 -35.6%
H
3.9
10.1
|
L
 -66.9%
H
3.9
39
|
L
 -95.2%
H
3.9
208.2
|
L
 -98.4%
H
3.9
690
|
L
 -100.0%
H
3.9
289500
|
| Precision Optics Corp Inc |
|
36.3
|
4.7
|
L
 6.6%
H
4.3
4.7
|
L
 10.8%
H
4.2
4.7
|
L
 15.4%
H
4.0
4.7
|
L
 9.5%
H
4.0
5.3
|
L
 -3.7%
H
3.8
5.3
|
L
 -20.2%
H
3.5
7.2
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
20,105.8
|
285.8
|
L
 0.6%
H
285.3
286.3
|
L
 2.8%
H
275.1
289.3
|
L
 -1.3%
H
275.1
299.8
|
L
 -12.6%
H
275.1
354.9
|
L
 3.6%
H
230.1
354.9
|
L
 -2.9%
H
125.8
354.9
|
L
 -2.5%
H
125.8
354.9
|
L
 730.4%
H
23.9
354.9
|
| Procept BioRobotics Corp |
|
1,704.9
|
30.5
|
L
 0.7%
H
30.3
30.7
|
L
 -0.2%
H
29.6
31.8
|
L
 -4.8%
H
29.6
35.4
|
L
 -12.1%
H
27.8
38.1
|
L
 -59.9%
H
27.8
77.0
|
L
 -21.0%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
270.9
|
16.1
|
L
 -0.8%
H
16.1
16.2
|
L
 1.7%
H
14.1
16.3
|
L
 -7.9%
H
14.1
18.5
|
L
 -0.9%
H
11.4
18.5
|
L
 184.5%
H
3.1
18.5
|
L
 -30.8%
H
2.9
24.8
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
288.2
|
7.9
|
L
 0.8%
H
7.9
7.9
|
L
 -5.3%
H
7.5
8.6
|
L
 4.1%
H
7
9.0
|
L
 37.4%
H
5.2
9.0
|
L
 8.0%
H
3.8
9.0
|
L
 -33.7%
H
3.8
15.5
|
L
 -68.7%
H
3.1
29.0
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
2,192.8
|
32.3
|
L
 -1.4%
H
32.2
32.7
|
L
 -3.1%
H
31.9
35.6
|
L
 11.5%
H
27.9
35.6
|
L
 11.3%
H
19.5
35.6
|
L
 -22.7%
H
19.5
46.2
|
L
 -63.4%
H
19.5
98.7
|
L
 -84.8%
H
19.5
265
|
L
 90.2%
H
13.2
306.7
|
| Quanterix Corp |
|
331.6
|
7.1
|
L
 1.1%
H
7.0
7.2
|
L
 -0.8%
H
6.8
8.1
|
L
 7.7%
H
6.2
8.8
|
L
 20.3%
H
4.5
8.8
|
L
 -20.0%
H
4.1
10.3
|
L
 -50.3%
H
4.1
29.7
|
L
 -90.7%
H
4.1
92.6
|
L
H
4.1
92.6
|
| AVITA Medical Inc |
|
118.0
|
3.9
|
L
 2.7%
H
3.8
3.9
|
L
 17.3%
H
3.3
3.9
|
L
 11.9%
H
3.2
3.9
|
L
 -3.5%
H
3.2
4.3
|
L
 -55.3%
H
3.2
11.3
|
L
 -55.2%
H
3.2
21.7
|
L
 -85.3%
H
3.2
28.5
|
L
 -42.7%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
50.0
|
1.3
|
L
 0.8%
H
1.3
1.3
|
L
 33.7%
H
0.9
1.3
|
L
 49.4%
H
0.8
1.3
|
L
 6.7%
H
0.8
1.3
|
L
 -40.1%
H
0.8
2.3
|
L
 -34.9%
H
0.8
6.2
|
L
 -91.0%
H
0.8
21.8
|
L
 -98.5%
H
0.8
116.4
|
| Vyome Holdings Inc |
|
15.6
|
2.8
|
L
 0.4%
H
2.7
2.8
|
L
 -10.9%
H
2.7
3.3
|
L
 -24.7%
H
2.7
3.9
|
L
 -48.9%
H
2.7
6.6
|
L
 -40.2%
H
0.3
12.9
|
L
 -99.4%
H
0.3
1299.2
|
L
 -100.0%
H
0.3
67860
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
43.3
|
0.7
|
L
 4.4%
H
0.7
0.8
|
L
 4.4%
H
0.7
0.8
|
L
 10.8%
H
0.6
0.8
|
L
 2.9%
H
0.5
0.8
|
L
 -44.6%
H
0.5
1.3
|
L
 -88.2%
H
0.5
9.1
|
L
 -94.9%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Sanmina Corp |
|
9,412.3
|
172.5
|
L
 -1.3%
H
171.0
178
|
L
 3.2%
H
163.9
181.0
|
L
 13.9%
H
144
181.0
|
L
 30.0%
H
124.4
181.0
|
L
 107.9%
H
63.7
181.0
|
L
 184.7%
H
43.4
181.0
|
L
 398.6%
H
30.6
181.0
|
L
 915.9%
H
16.9
181.0
|
| Sight Sciences Inc |
|
326.2
|
6.2
|
L
 -1.1%
H
6.2
6.3
|
L
 -9.7%
H
6.0
7.0
|
L
 -27.0%
H
6.0
9.2
|
L
 32.4%
H
4.5
9.2
|
L
 118.0%
H
2.0
9.2
|
L
 -50.6%
H
1.0
13.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,346.6
|
18.8
|
L
 0.7%
H
18.8
19.0
|
L
 -0.8%
H
18.6
19.4
|
L
 9.6%
H
17.1
19.9
|
L
 12.6%
H
15.0
19.9
|
L
 45.0%
H
9.5
19.9
|
L
 11.2%
H
9.5
19.9
|
L
 -28.4%
H
5.8
30.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
735.0
|
16.9
|
L
 0.1%
H
16.9
17.0
|
L
 -5.3%
H
16.7
17.9
|
L
 -16.9%
H
16.7
21.9
|
L
 11.3%
H
14.5
21.9
|
L
 1.5%
H
12.5
21.9
|
L
 -1.6%
H
11.7
29.5
|
L
 -42.1%
H
11.1
37.2
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
13.8
|
3.6
|
L
H
3.6
3.8
|
L
 -5.0%
H
3.6
3.8
|
L
 -0.6%
H
3.5
4.1
|
L
 7.2%
H
3.0
4.5
|
L
 12.9%
H
1.7
7.4
|
L
 -99.8%
H
0.1
2428
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
26064000
|
| Beauty Health Co (Class A) |
|
184.9
|
1.5
|
L
 0.7%
H
1.4
1.5
|
L
 -5.2%
H
1.4
1.6
|
L
 -5.2%
H
1.4
1.6
|
L
 4.3%
H
1.2
1.7
|
L
 -16.7%
H
0.8
2.7
|
L
 -87.1%
H
0.8
13.9
|
L
 -87.0%
H
0.8
30.2
|
L
H
0.8
30.2
|
| Sanara MedTech Inc |
|
198.4
|
22.2
|
L
 2.0%
H
21.9
22.2
|
L
 -6.2%
H
21.7
24.1
|
L
 -8.3%
H
21.7
26.0
|
L
 -24.8%
H
18.9
31.7
|
L
 -32.0%
H
18.9
38.7
|
L
 -53.7%
H
18.9
50.2
|
L
 -46.8%
H
17.4
50.2
|
L
 270%
H
2
75
|
| Sensus Healthcare Inc |
|
83.6
|
5.1
|
L
 2.6%
H
5
5.1
|
L
 -4.0%
H
4.9
5.3
|
L
 32.9%
H
3.7
5.5
|
L
 60.1%
H
3.1
5.5
|
L
 -22.4%
H
3.0
9.1
|
L
 -44.4%
H
1.8
9.3
|
L
 32.6%
H
1.8
15.3
|
L
H
1.8
15.3
|
| STRATA Skin Sciences Inc |
|
7.6
|
1.3
|
L
 0.8%
H
1.3
1.3
|
L
H
1.3
1.4
|
L
 8.4%
H
1.2
1.5
|
L
 -33.2%
H
1.2
2.3
|
L
 -55.7%
H
1.2
3.9
|
L
 -86.1%
H
1.2
41
|
L
 -93.7%
H
1.2
41
|
L
 -97.5%
H
1.2
76.5
|
| Staar Surgical Co. |
|
1,044.1
|
21.2
|
L
 0.9%
H
21.0
21.3
|
L
 0.1%
H
19.4
21.9
|
L
 -15.9%
H
19.4
25.7
|
L
 -16.5%
H
19.4
28.4
|
L
 -5.1%
H
13.5
30.8
|
L
 -70.1%
H
13.5
81.8
|
L
 -76.2%
H
13.5
163.1
|
L
 199.2%
H
5.0
163.1
|
| Neuronetics Inc |
|
136.3
|
2.0
|
L
 2.6%
H
2.0
2
|
L
 10.6%
H
1.7
2.0
|
L
 42.1%
H
1.3
2.1
|
L
 -27.1%
H
1.3
3.2
|
L
 -19.1%
H
1.3
5.9
|
L
 -67.0%
H
0.5
6.6
|
L
 -88.0%
H
0.5
22.4
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
33.4
|
10.3
|
L
 -1.1%
H
10.3
10.3
|
L
 -3.3%
H
10.2
11.0
|
L
 -5.6%
H
10.2
11.5
|
L
 -6%
H
9.3
11.5
|
L
 351.5%
H
1.7
12.0
|
L
 124.3%
H
1.7
12.0
|
L
 -42.4%
H
1.7
27
|
L
 -95.8%
H
1.7
307.5
|
| Sharps Tech Inc |
|
62.3
|
2.2
|
L
 -1.4%
H
2.1
2.2
|
L
 1.9%
H
2.0
2.4
|
L
 -3.2%
H
1.7
2.6
|
L
 -56.0%
H
1.7
5.5
|
L
 -99.6%
H
0.0
574.3
|
L
 -100.0%
H
0.0
13464
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
677.0
|
30.3
|
L
 1.0%
H
30
30.3
|
L
 1.2%
H
29.3
30.9
|
L
 4.8%
H
26.9
31.1
|
L
 107.5%
H
14.5
31.1
|
L
 74.2%
H
8.6
31.1
|
L
 145.4%
H
8.6
31.1
|
L
 -41.8%
H
6.3
64.5
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
42.7
|
1.0
|
L
 3.2%
H
1.0
1.0
|
L
 -10.3%
H
0.9
1.1
|
L
 -15.0%
H
0.9
1.2
|
L
 -35.1%
H
0.9
1.5
|
L
 -64.3%
H
0.9
3.0
|
L
 -92%
H
0.9
12.3
|
L
 -93.2%
H
0.9
18
|
L
H
0.9
23.5
|
| Tivic Health Systems Inc |
|
3.3
|
1.3
|
L
 2.4%
H
1.3
1.3
|
L
 1.6%
H
1.2
1.3
|
L
 -25.9%
H
1.2
2.5
|
L
 -54.7%
H
1.2
3.0
|
L
 -74.2%
H
1.2
15.6
|
L
 -99.9%
H
1.2
1445
|
L
H
1.2
11050
|
L
H
1.2
11050
|
| Treace Medical Concepts Inc |
|
172.7
|
2.7
|
L
 4.2%
H
2.6
2.7
|
L
H
2.6
2.8
|
L
 5.5%
H
2.4
3.1
|
L
 -60.2%
H
2.4
7.1
|
L
 -68.9%
H
2.4
10.8
|
L
 -89.6%
H
2.4
28.0
|
L
H
2.4
37.2
|
L
H
2.4
37.2
|
| Transmedics Grp Inc |
|
4,805.6
|
140.6
|
L
 -0.9%
H
139.6
142.8
|
L
 -1.5%
H
136
149.2
|
L
 10.1%
H
120.2
151.9
|
L
 17.3%
H
111.0
156
|
L
 145.8%
H
55
156
|
L
 118.6%
H
36.4
177.4
|
L
 498.4%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,418.4
|
20.9
|
L
 2.1%
H
20.7
20.9
|
L
 0.1%
H
19.6
22.0
|
L
 -5.2%
H
19.6
24.1
|
L
 34.6%
H
13.2
24.5
|
L
 -40.5%
H
10.0
37.9
|
L
 -51.0%
H
10.0
53.7
|
L
 -77.4%
H
10.0
155.9
|
L
 -74.5%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
13.1
|
0.7
|
L
H
0.7
0.7
|
L
H
0.7
0.7
|
L
 -22.2%
H
0.7
1.8
|
L
 -32.0%
H
0.7
1.8
|
L
 -96.6%
H
0.7
86
|
L
 -99.9%
H
0.7
775
|
L
 -100.0%
H
0.7
4262.5
|
L
 -100.0%
H
0.7
8550
|
| Utah Medical Products Inc |
|
196.4
|
61.3
|
L
H
60.7
61.6
|
L
 4.7%
H
58.2
62.2
|
L
 8.3%
H
55.8
62.2
|
L
 0.9%
H
53.7
62.2
|
L
 -1.4%
H
51.3
65.6
|
L
 -35.0%
H
51.3
100.6
|
L
 -30.5%
H
51.3
133.9
|
L
 4.1%
H
51.3
133.9
|
| Vivani Medical Inc |
|
102.9
|
1.4
|
L
 3.7%
H
1.4
1.5
|
L
 10.2%
H
1.2
1.5
|
L
 1.4%
H
1.2
1.5
|
L
 -24.6%
H
1.2
1.9
|
L
 17.5%
H
0.9
1.9
|
L
 16.5%
H
0.8
7.8
|
L
 -76.4%
H
0.8
60
|
L
 -98.6%
H
0.8
166.3
|
| Veracyte Inc |
|
3,269.5
|
41.4
|
L
 -0.8%
H
41.2
41.7
|
L
 -3.9%
H
40.3
43.0
|
L
 -3.6%
H
40.3
46.8
|
L
 12.9%
H
34.4
50.7
|
L
 1.9%
H
22.6
50.7
|
L
 66.2%
H
18.6
50.7
|
L
 -23.6%
H
14.9
86.0
|
L
 574.7%
H
4.2
86.0
|
| Venus Concept Inc |
|
4.1
|
2.2
|
L
 -50.6%
H
2.0
2.2
|
L
 52.8%
H
1.4
12.9
|
L
 14.6%
H
1.4
12.9
|
L
 -4.4%
H
1.4
12.9
|
L
 511.1%
H
0.3
14.5
|
L
 -54.4%
H
0.3
14.5
|
L
 -93.9%
H
0.3
51.6
|
L
H
0.3
2688.8
|
| Varex Imaging Corp |
|
575.6
|
13.7
|
L
 1.3%
H
13.7
13.7
|
L
 2.0%
H
13.4
14.0
|
L
 11.7%
H
11.5
14.0
|
L
 18.1%
H
9.8
14.0
|
L
 1.6%
H
6.8
15.5
|
L
 -35.8%
H
6.8
23.9
|
L
 -28.2%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
18.6
|
2.0
|
L
H
2.0
2.0
|
L
 1.0%
H
1.9
2.2
|
L
H
1.9
2.7
|
L
 -30.9%
H
1.9
3.1
|
L
 -65.7%
H
1.9
8.0
|
L
 -94.2%
H
1.9
48.8
|
L
 -98.8%
H
1.9
271.5
|
L
H
1.9
360.3
|
| Wrap Tech Inc |
|
134.5
|
2.6
|
L
 2.8%
H
2.6
2.7
|
L
 -14.1%
H
2.5
3.2
|
L
 14.5%
H
2.1
3.2
|
L
 1.2%
H
1.9
3.2
|
L
 26.7%
H
1.2
3.2
|
L
 9.2%
H
1.0
7.0
|
L
 -50.3%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
15.3
|
1.9
|
L
 -2.1%
H
1.9
2
|
L
 -12.8%
H
1.4
2.3
|
L
 109.9%
H
0.7
2.7
|
L
 -21.7%
H
0.7
2.7
|
L
 -77.2%
H
0.7
10.4
|
L
 -98.6%
H
0.7
154.8
|
L
 -98.5%
H
0.7
328.2
|
L
H
0.7
900
|
| DENTSPLY Sirona Inc |
|
2,450.5
|
12.3
|
L
 1.9%
H
12.1
12.3
|
L
 1.2%
H
12.0
12.6
|
L
 9.6%
H
11.0
12.9
|
L
 -5.0%
H
9.9
13.3
|
L
 -34.6%
H
9.9
20.6
|
L
 -66.8%
H
9.9
43.2
|
L
 -79.1%
H
9.9
69.5
|
L
 -78.3%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
8.5
|
0.9
|
L
 -7.2%
H
0.9
0.9
|
L
 -15.9%
H
0.8
1.0
|
L
 -72.5%
H
0.5
3.3
|
L
 -82.4%
H
0.5
5.5
|
L
 -86.5%
H
0.5
10.3
|
L
 -83.5%
H
0.5
20.0
|
L
 -93.9%
H
0.5
26.8
|
L
 -96.7%
H
0.5
31.8
|
| 111 Inc (ADR) |
|
44.0
|
5.1
|
L
H
4.8
5.5
|
L
 1.6%
H
4.8
6.9
|
L
 37.7%
H
2.5
6.9
|
L
 15.5%
H
2.5
6.9
|
L
 1081.4%
H
2.5
11.3
|
L
 63.9%
H
0.4
11.3
|
L
 -33.3%
H
0.4
45.9
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
20.4
|
0.1
|
L
H
0.1
0.1
|
L
 -45.8%
H
0.1
0.3
|
L
 -38.1%
H
0.1
0.3
|
L
 -61.8%
H
0.1
0.4
|
L
 -85.9%
H
0.1
1.0
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
| HeartBeam Inc |
|
69.2
|
2.0
|
L
H
2.0
2.0
|
L
 -16.3%
H
2.0
2.4
|
L
 -35.2%
H
2.0
3.2
|
L
 19.6%
H
0.5
4
|
L
 -6.1%
H
0.5
4
|
L
 27.2%
H
0.5
4
|
L
 27.2%
H
0.5
4
|
L
 27.2%
H
0.5
4
|
| Cencora |
|
67,496.1
|
347.9
|
L
 -0.8%
H
342.7
351.7
|
L
 0.6%
H
342.7
359.0
|
L
 2.1%
H
329.1
359.0
|
L
 6.3%
H
324.3
377.5
|
L
 43.7%
H
237.7
377.5
|
L
 114.5%
H
147.5
377.5
|
L
 235.2%
H
100.7
377.5
|
L
 282.8%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
124.6
|
0.4
|
L
H
0.4
0.4
|
L
 -5.3%
H
0.4
0.4
|
L
 -18.2%
H
0.4
0.5
|
L
 -5.3%
H
0.3
0.5
|
L
 -81.4%
H
0.1
2.3
|
L
 -93.4%
H
0.1
5.3
|
L
 -93.4%
H
0.1
5.3
|
L
 -93.4%
H
0.1
5.3
|
| Rewalk Robotics Ltd |
|
13.0
|
0.7
|
L
 -1.4%
H
0.7
0.7
|
L
 2.9%
H
0.7
0.8
|
L
 9.2%
H
0.6
0.8
|
L
 1.4%
H
0.5
0.8
|
L
 -56.7%
H
0.5
3.0
|
L
 -88.3%
H
0.5
9.1
|
L
 -94.9%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Work Medical Tech Grp Ltd |
|
2.4
|
2.0
|
L
 -4.4%
H
1.9
2.0
|
L
 -21.7%
H
1.9
2.7
|
L
 -62.6%
H
1.9
5.9
|
L
 -99.5%
H
1.9
836
|
L
 -100%
H
1.9
60000
|
L
H
1.9
84460
|
L
H
1.9
84460
|
L
H
1.9
84460
|
| iTonic Holdings Ordinary |
|
10.4
|
0.6
|
L
H
0.5
0.6
|
L
 41.9%
H
0.4
1.1
|
L
 22%
H
0.4
1.1
|
L
 -3.2%
H
0.4
1.1
|
L
 -84.1%
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
| Ceribell Inc |
|
796.4
|
21.5
|
L
 0.1%
H
21.5
21.5
|
L
 -5.8%
H
21.4
23.4
|
L
 1.3%
H
20.4
24.3
|
L
 71.8%
H
10.9
24.3
|
L
 2.0%
H
10.0
26.0
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
255.0
|
6.2
|
L
 7.7%
H
6.1
6.4
|
L
 37.9%
H
4.4
6.6
|
L
 25.3%
H
4.4
6.6
|
L
 4.4%
H
3.3
6.6
|
L
 3.3%
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
806.1
|
18.3
|
L
 -0.7%
H
18.2
18.4
|
L
 6.0%
H
16.0
19.0
|
L
 -37.4%
H
16.0
32.6
|
L
 -9.5%
H
16.0
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
| Wellgistics Health Inc |
|
39.9
|
0.4
|
L
H
0.4
0.4
|
L
 -7.1%
H
0.4
0.5
|
L
 -20.4%
H
0.4
0.5
|
L
 -9.3%
H
0.3
1.5
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
| Kestra Medical Tech Ltd |
|
1,361.9
|
23.3
|
L
 1.5%
H
22.7
23.5
|
L
 5.9%
H
21.4
23.5
|
L
 -14.6%
H
21.4
28.8
|
L
 -13.1%
H
21.4
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
237.9
|
27.7
|
L
 0.5%
H
27.7
27.7
|
L
 -2.9%
H
26.6
28.9
|
L
 -14.0%
H
26.6
32.9
|
L
 -11.4%
H
25.8
36.2
|
L
 -14.1%
H
24.8
46.6
|
L
 -14.1%
H
24.8
46.6
|
L
 -14.1%
H
24.8
46.6
|
L
 -14.1%
H
24.8
46.6
|
| SS Innovations Intl Inc |
|
1,095.9
|
5.7
|
L
 1.6%
H
5.7
5.7
|
L
 -4.6%
H
5.5
6.0
|
L
 -1.1%
H
5.1
6.2
|
L
 -43.3%
H
5.0
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
36,342.4
|
43.7
|
L
 -1.1%
H
43.7
45.1
|
L
 1.9%
H
41.5
45.1
|
L
 4.9%
H
38.5
45.5
|
L
 6.5%
H
38
45.5
|
L
 6.5%
H
38
45.5
|
L
 6.5%
H
38
45.5
|
L
 6.5%
H
38
45.5
|
L
 6.5%
H
38
45.5
|